• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Avanos Medical, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference

    1/7/26 8:25:00 PM ET
    $AVNS
    Industrial Specialties
    Health Care
    Get the next $AVNS alert in real time by email

    ALPHARETTA, Ga., Jan. 7, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today announced that Dave Pacitti, chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Tuesday, Jan. 13, at approximately 2:15 p.m. PST.

    (PRNewsfoto/Avanos Medical Inc.)

    A webcast of the conference presentation will be available on the Investors section of the Avanos Medical website and will be archived on that site.

    About Avanos Medical, Inc. 

    Avanos Medical, Inc. (NYSE:AVNS) is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, we are committed to addressing some of today's most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery. We develop, manufacture and market our recognized brands globally and hold leading market positions in multiple categories across our portfolio. For more information, visit www.avanos.com and follow Avanos Medical on X (@AvanosMedical), LinkedIn and Facebook.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/avanos-medical-inc-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-302655855.html

    SOURCE Avanos Medical

    Get the next $AVNS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AVNS

    DatePrice TargetRatingAnalyst
    7/25/2023Overweight → Sector Weight
    KeyBanc Capital Markets
    5/22/2023$31.00Buy
    CL King
    2/24/2022$47.00 → $41.00Overweight
    Keybanc
    1/7/2022$37.00 → $36.00Underweight
    Morgan Stanley
    8/4/2021$45.00 → $41.00Underweight
    Morgan Stanley
    8/4/2021$60.00 → $45.00Overweight → Equal-Weight
    Stephens
    8/4/2021$55.00 → $47.00Overweight
    Keybanc
    More analyst ratings

    $AVNS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors

    Pulse Biosciences, Inc. (NASDAQ:PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced the appointment of Maria Sainz to its Board of Directors effective as of January 9, 2026. "We are delighted to welcome Maria to our Board of Directors," said Pulse Biosciences' Co-Chairman of the Board Robert W. Duggan. "She brings an exceptionally strong track record of guiding both public and private medical device companies through growth, commercialization, viability, and scale. Her strategic and operational expertise will be invaluable as Pulse begins creating and disrupting interventional m

    1/9/26 7:00:00 AM ET
    $AVNS
    $HYPR
    $OFIX
    Industrial Specialties
    Health Care
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Medical/Dental Instruments

    Avanos Medical, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference

    ALPHARETTA, Ga., Jan. 7, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today announced that Dave Pacitti, chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, California, on Tuesday, Jan. 13, at approximately 2:15 p.m. PST. A webcast of the conference presentation will be available on the Investors section of the Avanos Medical website and will be archived on that site. About Avanos Medical, Inc. Avanos Medical, Inc. (NYSE:AVNS) is a medical technology company focused on delivering clinically superior medical devi

    1/7/26 8:25:00 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    Avanos Medical, Inc. Announces Third Quarter 2025 Results

    Delivered double-digit growth in Specialty Nutrition Systems segmentClosed acquisition of Nexus Medical, providing a complementary technology for the Specialty Nutrition Systems segmentRaising and narrowing top-line guidance and adjusted EPS guidance for the full yearALPHARETTA, Ga., Nov. 5, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported third quarter 2025 financial results. "I am pleased with our third quarter results, both operationally and commercially," said David Pacitti, Avanos' chief executive officer. Pacitti continued, "Avanos delivered double-di

    11/5/25 7:00:00 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    $AVNS
    SEC Filings

    View All

    Amendment: Avanos Medical Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K/A - AVANOS MEDICAL, INC. (0001606498) (Filer)

    12/5/25 4:03:07 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    SEC Form SCHEDULE 13G filed by Avanos Medical Inc.

    SCHEDULE 13G - AVANOS MEDICAL, INC. (0001606498) (Subject)

    11/14/25 6:39:46 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    SEC Form 10-Q filed by Avanos Medical Inc.

    10-Q - AVANOS MEDICAL, INC. (0001606498) (Filer)

    11/5/25 4:28:31 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    $AVNS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Chief Commercial Officer Holbrook Kerr sold $165,014 worth of shares (15,000 units at $11.00), decreasing direct ownership by 15% to 83,860 units (SEC Form 4)

    4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)

    11/19/25 1:45:33 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    Principal Accounting Officer Hurley John Joseph covered exercise/tax liability with 345 shares, decreasing direct ownership by 3% to 11,364 units (SEC Form 4)

    4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)

    9/9/25 12:55:39 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    New insider Galovan Scott Michael claimed ownership of 111,009 shares (SEC Form 3)

    3 - AVANOS MEDICAL, INC. (0001606498) (Issuer)

    8/22/25 2:40:41 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    $AVNS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Blackford Gary bought $659,300 worth of shares (60,000 units at $10.99), increasing direct ownership by 28% to 91,593 units (SEC Form 4)

    4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)

    8/15/25 12:02:50 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    Shimer Julie Ann bought $9,925 worth of shares (500 units at $19.85), increasing direct ownership by 1% to 50,090 units (SEC Form 4)

    4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)

    3/11/24 5:15:37 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    $AVNS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Avanos Medical downgraded by KeyBanc Capital Markets

    KeyBanc Capital Markets downgraded Avanos Medical from Overweight to Sector Weight

    7/25/23 6:15:12 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    CL King initiated coverage on Avanos Medical with a new price target

    CL King initiated coverage of Avanos Medical with a rating of Buy and set a new price target of $31.00

    5/22/23 8:52:10 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    Keybanc reiterated coverage on Avanos Medical with a new price target

    Keybanc reiterated coverage of Avanos Medical with a rating of Overweight and set a new price target of $41.00 from $47.00 previously

    2/24/22 4:48:01 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    $AVNS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Avanos Medical Inc.

    SC 13G - AVANOS MEDICAL, INC. (0001606498) (Subject)

    11/14/24 1:28:34 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Avanos Medical Inc. (Amendment)

    SC 13G/A - AVANOS MEDICAL, INC. (0001606498) (Subject)

    2/14/24 11:41:02 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Avanos Medical Inc. (Amendment)

    SC 13G/A - AVANOS MEDICAL, INC. (0001606498) (Subject)

    2/13/24 4:58:57 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    $AVNS
    Leadership Updates

    Live Leadership Updates

    View All

    Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors

    Pulse Biosciences, Inc. (NASDAQ:PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced the appointment of Maria Sainz to its Board of Directors effective as of January 9, 2026. "We are delighted to welcome Maria to our Board of Directors," said Pulse Biosciences' Co-Chairman of the Board Robert W. Duggan. "She brings an exceptionally strong track record of guiding both public and private medical device companies through growth, commercialization, viability, and scale. Her strategic and operational expertise will be invaluable as Pulse begins creating and disrupting interventional m

    1/9/26 7:00:00 AM ET
    $AVNS
    $HYPR
    $OFIX
    Industrial Specialties
    Health Care
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Medical/Dental Instruments

    Avanos Medical Announces Appointment of Scott Galovan as Senior Vice President, Chief Financial Officer; David Pacitti Appointed to Board of Directors

    ALPHARETTA, Ga., Aug. 5, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS), a leading medical technology company, today announced the appointment of Scott Galovan as its new senior vice president, chief financial officer, effective Aug. 1, 2025. Galovan most recently served as Avanos' senior vice president of strategy and corporate development. His background with the company spans 12 years and is highlighted by a proven track record of leading a number of acquisition and divestiture initiatives. Prior to Avanos, he spent 10 years in a variety of strategy, finance, and M&A

    8/5/25 6:45:00 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    Avanos Medical, Inc. Welcomes Camille Chang Gilmore as Senior Vice President and Chief Human Resources Officer

    ALPHARETTA, Ga., June 9, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) a leading medical technology company focused on delivered innovative healthcare solutions, today announced the appointment of Camille Chang Gilmore as senior vice president and chief human resources officer. In this role, Gilmore will lead all aspects of Avanos' people strategy, including talent acquisition and development, workforce planning, leadership development and employee experience. Her arrival reflects the company's continued commitment to building a workplace where every employee feels val

    6/9/25 7:15:00 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    $AVNS
    Financials

    Live finance-specific insights

    View All

    Avanos Medical, Inc. Announces Third Quarter 2025 Results

    Delivered double-digit growth in Specialty Nutrition Systems segmentClosed acquisition of Nexus Medical, providing a complementary technology for the Specialty Nutrition Systems segmentRaising and narrowing top-line guidance and adjusted EPS guidance for the full yearALPHARETTA, Ga., Nov. 5, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported third quarter 2025 financial results. "I am pleased with our third quarter results, both operationally and commercially," said David Pacitti, Avanos' chief executive officer. Pacitti continued, "Avanos delivered double-di

    11/5/25 7:00:00 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2025 Financial Results

    ALPHARETTA, Ga., Oct. 27, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2025 on Wed., Nov. 5, at 9 a.m. ET. The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Dave Pacitti, chief executive officer, and Scott Galovan, senior vice president and chief financial officer. To instantly join the conference call by phone, use the following link to register close to the call start time:

    10/27/25 10:31:00 AM ET
    $AVNS
    Industrial Specialties
    Health Care

    Avanos Medical Acquires Nexus Medical to Strengthen Nutrition and Medication Delivery in Critical Care

    ALPHARETTA, Ga., Sept. 15, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS), a leading medical technology company, today announced the acquisition of Nexus Medical, LLC, a privately held medical device company based in Lenexa, Kansas. Nexus is the maker of the proprietary TKO® anti-reflux needleless connector technology, designed to support safer, more consistent nutrition and medication delivery in high-acuity settings, including Neonatal and Pediatric Intensive Care Units (NICUs and PICUs). The acquisition adds complementary technology to Avanos' Specialty Nutrition Sys

    9/15/25 7:00:00 AM ET
    $AVNS
    Industrial Specialties
    Health Care